Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |